(Q39604319)

13 September 2017

De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer (English)

1 reference

13 September 2017

1 reference

1 reference

Paradis V

1

1 reference

13 September 2017

Eschwège P

2

1 reference

13 September 2017

Loric S

3

1 reference

13 September 2017

Dumas F

4

1 reference

13 September 2017

Ba N

5

1 reference

13 September 2017

Benoît G

6

1 reference

13 September 2017

Jardin A

7

1 reference

13 September 2017

Bedossa P

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

Journal of Clinical Pathology

13 September 2017

1 reference

13 September 2017

51

1 reference

13 September 2017

798-802

1 reference

13 September 2017

11

1 reference

CD44 and CD44v6 downregulation in clinical prostatic carcinoma: relation to Gleason grade and cytoarchitecture.

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Cell-cell interaction in prostate gene regulation and cytodifferentiation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Glioma invasion in vitro is mediated by CD44-hyaluronan interactions.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

17 June 2018

Cancer statistics, 1994.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

De-novo expression of CD44 and survival in gastric cancer

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Expression of CD44 in prostate cancer cells

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=500969

Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen

4 November 2018

1 reference

12 December 2020

Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma

1 reference

12 December 2020

Expression of CD44 isoforms in human prostate tumor cell lines

1 reference

12 December 2020

Accumulation of p53 and expression of CD44 in human prostatic cancer and benign prostatic hyperplasia: an immunohistochemical study

1 reference

12 December 2020

Altered expression of CD44 in human prostate cancer during progression

1 reference

12 December 2020

Pathologic classification of prostate carcinoma: the impact of margin status

1 reference

12 December 2020

Intraductal dysplasia: a premalignant lesion of the prostate

1 reference

12 December 2020

Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens

1 reference

12 December 2020

Significance of CD44 gene products for cancer diagnosis and disease evaluation

1 reference

12 December 2020

Expression of CD44R1 adhesion molecule in colon carcinomas and metastases

1 reference

12 December 2020

Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression

1 reference

12 December 2020

Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.51.11.798

1 reference

13 September 2017

1 reference

13 September 2017

1 reference